1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ARBUTUS BIOPHARMA CORP
Arbutus Biopharma Corp
XNAS: ABUS
Download real time
4.35 0.04 (0.93%)
47.96% Gain from 52W Low
924.9K
XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Arbutus Biopharma Corp is on 21 May 2026 for the purpose of Arbutus Biopharma Corp Annual General Meeting for 2026 See details

Arbutus Biopharma Corp - ABUS - stock price prediction, stock price target, analyst ratings from 3 analysts

Arbutus Biopharma Corp has a share price target of US$ 5, revenue growth forecast of -69.7%, and profit growth estimate of 59.7% for FY26, based on top 3 analyst calls.

Forecaster Screeners